Immuno-oncology trends: preclinical models, biomarkers, and clinical development

The landscape in immuno-oncology (I-O) has undergone profound changes since its early beginnings up through the rapid advances happening today. The current drug development pipeline consists of thousands of potential I-O therapies and therapy combinations, many of which are being evaluated in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Franklin, Maryland Rosenfeld, Platero, Suso, Saini, Kamal S, Curigliano, Giuseppe, Anderson, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756278/
https://www.ncbi.nlm.nih.gov/pubmed/35022192
http://dx.doi.org/10.1136/jitc-2021-003231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756278/
https://www.ncbi.nlm.nih.gov/pubmed/35022192
http://dx.doi.org/10.1136/jitc-2021-003231

Ejemplares similares